Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-02-25 @ 6:57 PM
Study NCT ID:
NCT01794520
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2012-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed/Refractory Multiple Myeloma | View |